The 17 companies at the center of TrumpRx didn't wait for the White House to unveil its February 2026 prescription drug-pricing plan — they built it. Per OpenSecrets, those firms accounted for more than a quarter of the pharmaceutical industry's record $457.3 million in 2025 federal lobbying. The play is straightforward: flood the zone while the rules are being written, then stand next to the president at the ribbon-cutting. Citizens United made the flood cheaper; TrumpRx made it profitable.